Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
European Journal of Immunology
|
February 23, 2011
CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions
Benjamin Weber, Leslie Saurer, Mirjam Schenk, et al.
Journal of Immunological Methods
|
March 13, 2009
Quantitative isolation of mouse and human intestinal intraepithelial lymphocytes by elutriation centrifugation
Elisa Binda, Dominik Erhart, Mirjam Schenk, et al.
Cancers
|
April 30, 2021
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
Thomas Gruber, Steve Robatel, Mirela Kremenovic, et al.
Frontiers in Immunology
|
October 5, 2020
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Fabienne Maibach, Hassan Sadozai, S Morteza Seyed Jafari, et al.
Frontiers in Immunology
|
March 8, 2021
Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer
Hassan Sadozai, Animesh Acharjee, Serenella Eppenberger-Castori, et al.
Cancers
|
June 4, 2020
Characterization of a Myeloid Activation Signature that Correlates with Survival in Melanoma Patients
Mirela Kremenovic, Nives Rombini, Alfred A Chan, et al.
Nature Communications
|
April 22, 2015
Combinatorial code governing cellular responses to complex stimuli
Antonio Cappuccio, Raphaël Zollinger, Mirjam Schenk, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2022
BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma
Mirela Kremenovic, Alfred A Chan, Bing Feng, et al.
Infection and Immunity
|
June 15, 2016
Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae
Mirjam Schenk, Sebabrata Mahapatra, Phuonganh Le, et al.
Molecular Therapy. Oncology
|
September 8, 2025
TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma
Lina Gross, Ivanina Mutisheva, Hanne Hillen, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
European Journal of Immunology
|
February 23, 2011
CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions
Benjamin Weber, Leslie Saurer, Mirjam Schenk, et al.
Journal of Immunological Methods
|
March 13, 2009
Quantitative isolation of mouse and human intestinal intraepithelial lymphocytes by elutriation centrifugation
Elisa Binda, Dominik Erhart, Mirjam Schenk, et al.
Cancers
|
April 30, 2021
Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
Thomas Gruber, Steve Robatel, Mirela Kremenovic, et al.
Frontiers in Immunology
|
October 5, 2020
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Fabienne Maibach, Hassan Sadozai, S Morteza Seyed Jafari, et al.
Frontiers in Immunology
|
March 8, 2021
Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer
Hassan Sadozai, Animesh Acharjee, Serenella Eppenberger-Castori, et al.
Cancers
|
June 4, 2020
Characterization of a Myeloid Activation Signature that Correlates with Survival in Melanoma Patients
Mirela Kremenovic, Nives Rombini, Alfred A Chan, et al.
Nature Communications
|
April 22, 2015
Combinatorial code governing cellular responses to complex stimuli
Antonio Cappuccio, Raphaël Zollinger, Mirjam Schenk, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2022
BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma
Mirela Kremenovic, Alfred A Chan, Bing Feng, et al.
Infection and Immunity
|
June 15, 2016
Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae
Mirjam Schenk, Sebabrata Mahapatra, Phuonganh Le, et al.
Molecular Therapy. Oncology
|
September 8, 2025
TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma
Lina Gross, Ivanina Mutisheva, Hanne Hillen, et al.
Page
of 5